AIIMS Patna Declared as Centre of Excellence for Rare Diseases by MoHFW

Date:

Share post:

 

AIIMS Patna Declared as Centre of Excellence for Rare Diseases by MoHFW

PharmaGenDRx News Bureau- 20th August,2025

10:00 AM IST

All India Institute of Medical Sciences (AIIMS), Patna was declared as a Centre of Excellence (CoE) for Rare Diseases under the National Policy for Rare Diseases (NPRD), 2021 by the Ministry of Health and Family Welfare.

Hereby AIIMS Patna becomes another CoEs to provide advanced diagnosis, prevention and treatment for patients affected by rare diseases reaffirming the Government’s commitment towards uplifting the infrastructure of tertiary healthcare. This is a promising step towards safeguarding public healthcare.

With this move AIIMS Patna is endorsed with responsibilities to continue their work towards providing sufficient aid in the nation-wide fight against rare words.

By Sharon Bose and Arundhuti Chatterjee

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

MSD Inaugurates New Technology Centre in Hyderabad to Drive Global Healthcare Innovation and Digital Capabilities

MSD (Merck & Co., Inc.), one of the world's leading global life sciences companies, has officially inaugurated its...

Bharat Technology Announces BT-PHARMACON 2K26 with Focus on Indigenous Pharma Innovation

Bharat Technology is set to organise BT-PHARMACON 2K26, an ANRF-sponsored national conference on September 26–27, 2026, at the Eastern Zonal...

ChrysCapital to Acquire 20-25% Stake in Linux Laboratories for ₹600 Crore

Private equity firm ChrysCapital is all set to acquire a strategic stake in Linux Laboratories, a Chennai-based specialty pharmaceutical company focused on central nervous...

India Spotlights Massive Health Workforce Expansion at WHO RC79; SEARO Adopts Historic Dili Declaration

The Ministerial Roundtable addressing on"Human Resources for Health: Equity in Specialized Care" at the 79th Session of the WHO Regional...